One-Year Coverage by Optical Coherence Tomography of a Bioresorbable Scaffold Neocarina: Is It Safe to Discontinue Dual-Antiplatelet Therapy?

Can J Cardiol. 2015 Sep;31(9):1205.e5-6. doi: 10.1016/j.cjca.2015.03.029. Epub 2015 Mar 31.

Authors

Piera Capranzano¹, Bruno Francaviglia², Claudia Ina Tamburino², Giuseppe Gargiulo², Giovanni Longo², Davide Capodanno², Corrado Tamburino²

Affiliations

¹ Cardiovascular Department, Ferrarotto Hospital, University of Catania, Catania, Italy. Electronic address: [email protected].
² Cardiovascular Department, Ferrarotto Hospital, University of Catania, Catania, Italy.

PMID: 26118449
DOI: 10.1016/j.cjca.2015.03.029

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Coronary Occlusion / surgery*
Everolimus / administration & dosage*
Humans
Male
Platelet Aggregation Inhibitors / administration & dosage*
Prosthesis Design
Sirolimus / administration & dosage
Sirolimus / analogs & derivatives*
Tissue Scaffolds*
Tomography, Optical Coherence*

Substances

Platelet Aggregation Inhibitors
Everolimus
zotarolimus
Sirolimus